Malaria prophylaxis
Malaria Prophylaxis[edit]

Malaria prophylaxis refers to the preventive treatment of malaria, a disease caused by Plasmodium parasites transmitted through the bites of infected Anopheles mosquitoes. Prophylactic measures are crucial for travelers to endemic regions and for populations living in areas where malaria is prevalent.
Types of Prophylaxis[edit]
Malaria prophylaxis can be divided into two main categories: chemoprophylaxis and non-chemoprophylactic measures.
Chemoprophylaxis[edit]
Chemoprophylaxis involves the use of antimalarial drugs to prevent infection. The choice of drug depends on the region of travel, the resistance patterns of the malaria parasites, and individual health considerations.
- Chloroquine: Once widely used, chloroquine is now effective only in areas where the parasites have not developed resistance.
- Mefloquine: Effective in many regions, but associated with neuropsychiatric side effects in some individuals.
- Doxycycline: An antibiotic that is also effective as a prophylactic agent against malaria.
- Atovaquone/proguanil: A combination drug that is well-tolerated and effective in many regions.
Non-chemoprophylactic Measures[edit]
Non-chemoprophylactic measures include strategies to avoid mosquito bites, such as:
- Using insect repellents containing DEET or picaridin.
- Sleeping under insecticide-treated bed nets.
- Wearing long-sleeved clothing and long pants, especially during dusk and dawn when mosquitoes are most active.
- Staying in accommodations with screened windows and doors or air conditioning.
Considerations for Prophylaxis[edit]
The choice of prophylactic measures should consider the following factors:
- Destination: The specific region and its malaria transmission patterns.
- Duration of stay: Longer stays may require different prophylactic strategies.
- Health status: Pre-existing conditions and potential drug interactions.
- Pregnancy: Some drugs are contraindicated during pregnancy.
Challenges in Malaria Prophylaxis[edit]

Challenges in malaria prophylaxis include drug resistance, side effects of prophylactic medications, and adherence to preventive measures. Resistance to antimalarial drugs is a significant concern, necessitating ongoing research and development of new prophylactic agents.
Related pages[edit]
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian